Published in Cardiorenal Med on September 30, 2016
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol (2006) 3.36
How fibroblast growth factor 23 works. J Am Soc Nephrol (2007) 2.92
Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet (2005) 2.21
Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res (2003) 2.05
Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens (2006) 1.81
Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem (2002) 1.79
The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med (2004) 1.28
Approach to the hypophosphatemic patient. J Clin Endocrinol Metab (2012) 1.16
Calcium regulates FGF-23 expression in bone. Endocrinology (2013) 1.09
Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect (2014) 0.89
Genetic disorders of phosphate regulation. Pediatr Nephrol (2012) 0.86
Renal phosphate transporters. Curr Opin Nephrol Hypertens (2014) 0.85
The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease. Cardiorenal Med (2011) 0.85
Phosphate Metabolism in Cardiorenal Metabolic Disease. Cardiorenal Med (2011) 0.84
The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program. Cardiorenal Med (2013) 0.82
Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment. Osteoporos Int (2016) 0.81